311 related articles for article (PubMed ID: 12535159)
1. The melanocortin agonist Melanotan-II reduces the orexigenic and adipogenic effects of neuropeptide Y (NPY) but does not affect the NPY-driven suppressive effects on the gonadotropic and somatotropic axes in the male rat.
Raposinho PD; White RB; Aubert ML
J Neuroendocrinol; 2003 Feb; 15(2):173-81. PubMed ID: 12535159
[TBL] [Abstract][Full Text] [Related]
2. Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axes.
Raposinho PD; Castillo E; d'Alleves V; Broqua P; Pralong FP; Aubert ML
Endocrinology; 2000 Dec; 141(12):4419-27. PubMed ID: 11108250
[TBL] [Abstract][Full Text] [Related]
3. Relationship between alpha-melanocyte-stimulating hormone- and neuropeptide Y-containing neurons in the goldfish hypothalamus.
Kojima K; Amiya N; Kamijo M; Kageyama H; Uchiyama M; Shioda S; Matsuda K
Gen Comp Endocrinol; 2010 Jul; 167(3):366-72. PubMed ID: 20005228
[TBL] [Abstract][Full Text] [Related]
4. Melanocortin 4 receptor-mediated hyperphagia and activation of neuropeptide Y expression in the dorsomedial hypothalamus during lactation.
Chen P; Williams SM; Grove KL; Smith MS
J Neurosci; 2004 Jun; 24(22):5091-100. PubMed ID: 15175378
[TBL] [Abstract][Full Text] [Related]
5. Anorectic effects of the cytokine, ciliary neurotropic factor, are mediated by hypothalamic neuropeptide Y: comparison with leptin.
Xu B; Dube MG; Kalra PS; Farmerie WG; Kaibara A; Moldawer LL; Martin D; Kalra SP
Endocrinology; 1998 Feb; 139(2):466-73. PubMed ID: 9449612
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y counteracts the anorectic and weight reducing effects of ciliary neurotropic factor.
Pu S; Dhillon H; Moldawer LL; Kalra PS; Kalra SP
J Neuroendocrinol; 2000 Sep; 12(9):827-32. PubMed ID: 10971807
[TBL] [Abstract][Full Text] [Related]
7. Chronic neuropeptide Y infusion into the lateral ventricle induces sustained feeding and obesity in mice lacking either Npy1r or Npy5r expression.
Raposinho PD; Pedrazzini T; White RB; Palmiter RD; Aubert ML
Endocrinology; 2004 Jan; 145(1):304-10. PubMed ID: 14525913
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of central neuropeptide Y on the somatotropic and gonadotropic axes in male rats are independent of adrenal hormones.
Sainsbury A; Herzog H
Peptides; 2001 Mar; 22(3):467-71. PubMed ID: 11287103
[TBL] [Abstract][Full Text] [Related]
9. Enhanced inhibitory feeding response to alpha-melanocyte stimulating hormone in the diet-induced obese rat.
Hansen MJ; Ball MJ; Morris MJ
Brain Res; 2001 Feb; 892(1):130-7. PubMed ID: 11172758
[TBL] [Abstract][Full Text] [Related]
10. Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and the somatotropic axis in intact adult female rats.
Catzeflis C; Pierroz DD; Rohner-Jeanrenaud F; Rivier JE; Sizonenko PC; Aubert ML
Endocrinology; 1993 Jan; 132(1):224-34. PubMed ID: 8380374
[TBL] [Abstract][Full Text] [Related]
11. Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growth factor I secretion in intact adult male rats.
Pierroz DD; Catzeflis C; Aebi AC; Rivier JE; Aubert ML
Endocrinology; 1996 Jan; 137(1):3-12. PubMed ID: 8536627
[TBL] [Abstract][Full Text] [Related]
12. Hyperphagia and obesity produced by arcuate injection of NPY-saporin do not require upregulation of lateral hypothalamic orexigenic peptide genes.
Li AJ; Dinh TT; Ritter S
Peptides; 2008 Oct; 29(10):1732-9. PubMed ID: 18577407
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of methamphetamine on expression of neuropeptide Y mRNA in hypothalamus and on serum leptin and ghrelin concentrations in ad libitum-fed and schedule-fed rats.
Crowley WR; Ramoz G; Keefe KA; Torto R; Kalra SP; Hanson GR
Neuroscience; 2005; 132(1):167-73. PubMed ID: 15780475
[TBL] [Abstract][Full Text] [Related]
14. Chronic central melanocortin-4 receptor antagonism and central neuropeptide-Y infusion in rats produce increased adiposity by divergent pathways.
Baran K; Preston E; Wilks D; Cooney GJ; Kraegen EW; Sainsbury A
Diabetes; 2002 Jan; 51(1):152-8. PubMed ID: 11756335
[TBL] [Abstract][Full Text] [Related]
15. Functional interactions between melanin-concentrating hormone, neuropeptide Y, and anorectic neuropeptides in the rat hypothalamus.
Tritos NA; Vicent D; Gillette J; Ludwig DS; Flier ES; Maratos-Flier E
Diabetes; 1998 Nov; 47(11):1687-92. PubMed ID: 9792536
[TBL] [Abstract][Full Text] [Related]
16. Melanocortinergic activation by melanotan II inhibits feeding and increases uncoupling protein 1 messenger ribonucleic acid in the developing rat.
Glavas MM; Joachim SE; Draper SJ; Smith MS; Grove KL
Endocrinology; 2007 Jul; 148(7):3279-87. PubMed ID: 17412803
[TBL] [Abstract][Full Text] [Related]
17. Resistance to the satiety action of leptin following chronic central leptin infusion is associated with the development of leptin resistance in neuropeptide Y neurones.
Sahu A
J Neuroendocrinol; 2002 Oct; 14(10):796-804. PubMed ID: 12372004
[TBL] [Abstract][Full Text] [Related]
18. Interactions of neuropeptide Y, hypocretin-I (orexin A) and melanin-concentrating hormone on feeding in rats.
Sahu A
Brain Res; 2002 Jul; 944(1-2):232-8. PubMed ID: 12106685
[TBL] [Abstract][Full Text] [Related]
19. Leptin regulates appetite-related neuropeptides in the hypothalamus of developing rats without affecting food intake.
Proulx K; Richard D; Walker CD
Endocrinology; 2002 Dec; 143(12):4683-92. PubMed ID: 12446596
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y in central control of feeding and interactions with orexin and leptin.
Niimi M; Sato M; Taminato T
Endocrine; 2001 Mar; 14(2):269-73. PubMed ID: 11394646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
